The role of FOXP3 in disease progression in colorectal cancer patients
Authors:
Open Access
- 1 June 2013
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 2 (6) , e24521
Abstract
The transcription factor forkhead box P3 (FOXP3) has been identified as a marker of CD4+CD25+ regulatory T cells and is a key determinant of their immunosuppressive functions. FOXP3 has indeed been shown to limit antitumor immune responses during tumor progression. In addition, by expressing FOXP3, tumor cells may evade effector T-cell responses.Keywords
This publication has 10 references indexed in Scilit:
- Expression of Foxp3 in Colorectal Cancer but Not in Treg Cells Correlates with Disease Progression in Patients with Colorectal CancerPLOS ONE, 2013
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal CancerJournal of Clinical Oncology, 2009
- Foxp3 expression in human cancer cellsJournal of Translational Medicine, 2008
- Foxp3 Expression in Pancreatic Carcinoma Cells as a Novel Mechanism of Immune Evasion in CancerCancer Research, 2007
- Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After ResectionJournal of Clinical Oncology, 2007
- Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant LesionsClinical Cancer Research, 2006
- Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cellsProceedings of the National Academy of Sciences, 2005
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- Regulatory T CellsCell, 2000
- Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implicationsMolecular Medicine Today, 1998